A detailed history of 11 Capital Partners LP transactions in Danaher Corp stock. As of the latest transaction made, 11 Capital Partners LP holds 42,679 shares of DHR stock, worth $9.75 Million. This represents 5.26% of its overall portfolio holdings.

Number of Shares
42,679
Previous 20,039 112.98%
Holding current value
$9.75 Million
Previous $5.01 Million 137.0%
% of portfolio
5.26%
Previous 2.21%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$239.25 - $280.76 $5.42 Million - $6.36 Million
22,640 Added 112.98%
42,679 $11.9 Million
Q2 2024

Aug 13, 2024

SELL
$235.51 - $267.98 $6.43 Million - $7.32 Million
-27,300 Reduced 57.67%
20,039 $5.01 Million
Q1 2024

May 15, 2024

BUY
$224.58 - $256.19 $923,248 - $1.05 Million
4,111 Added 9.51%
47,339 $11.8 Million
Q4 2023

Feb 13, 2024

BUY
$185.1 - $233.13 $8 Million - $10.1 Million
43,228 New
43,228 $10 Million
Q2 2022

Aug 15, 2022

SELL
$237.11 - $299.66 $12.2 Million - $15.4 Million
-51,536 Reduced 53.65%
44,527 $11.3 Million
Q1 2022

May 16, 2022

BUY
$257.27 - $315.76 $7.49 Million - $9.2 Million
29,132 Added 43.53%
96,063 $28.2 Million
Q4 2021

Feb 14, 2022

BUY
$292.08 - $329.01 $3.48 Million - $3.92 Million
11,900 Added 21.62%
66,931 $22 Million
Q3 2021

Nov 15, 2021

SELL
$272.21 - $332.43 $6.83 Million - $8.34 Million
-25,075 Reduced 31.3%
55,031 $16.8 Million
Q2 2021

Aug 16, 2021

BUY
$225.08 - $271.69 $4.55 Million - $5.49 Million
20,194 Added 33.71%
80,106 $21.5 Million
Q1 2021

May 17, 2021

SELL
$212.38 - $245.9 $912,596 - $1.06 Million
-4,297 Reduced 6.69%
59,912 $13.5 Million
Q4 2020

Feb 12, 2021

BUY
$212.5 - $245.46 $13.6 Million - $15.8 Million
64,209 New
64,209 $14.3 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $166B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track 11 Capital Partners LP Portfolio

Follow 11 Capital Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 11 Capital Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on 11 Capital Partners LP with notifications on news.